Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMPH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,884
Award facts
- Contract value 100% obligated
- $14,883.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,883.90 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on December 10, 2025, with an ultimate completion date of December 11, 2025, represents a purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The PPV-G GEN V is a $30.3 billion acquisition strategy designed to establish regional prime vendor contractors who supply comprehensive pharmaceutical products and medical consumables to Department of Defense military healthcare facilities worldwide. No set-aside designation was used for this award, demonstrating the contractor's competitive capability in unrestricted federal procurement.
DMS Pharmaceutical Group Inc. supplies an extensive portfolio of pharmaceuticals spanning branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceutical products to support DoD medical operations. The company holds a single-award IDC under the PPV-G GEN V contract (SPE2DR), valued at $499,999,999 with a completion date of December 31, 2036, which authorizes the DLA to issue delivery orders for recurring pharmaceutical supply needs. DMS Pharmaceutical Group's established performance across numerous previous delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system with no subcontractors identified in the award documentation.
Quick answers
Who was awarded contract SPE2DU26FEMPH?
SPE2DU26FEMPH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DU26FEMPH worth?
The government has obligated $14,884 on SPE2DU26FEMPH.
Is contract SPE2DU26FEMPH an order under another contract?
Yes. SPE2DU26FEMPH is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMPH competed?
The extent of competition for SPE2DU26FEMPH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award